✦ LIBER ✦

PCV103 COST-EFFECTIVENESS OF EXTENDED VERSUS NON-EXTENDED PROPHYLAXIS WITH ENOXAPARIN IN HIGH-RISK SURGICAL PATIENTS IN AUSTRALIA

✍ Scribed by D Tilden; JM Lee

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV90 COST EFFECTIVENESS OF FONDAPARINUX

✍ B Van Hout; BV Pharmerit 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCV72 COST-EFFECTIVENESS OF EXTENDED-REL

✍ K Jameson; GM Davies; BM Ambegaonkar; V Sazonov; C O'Regan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Extended prophylaxis of venous thromboem

✍ Stefano Capri; Walter Ageno; Davide Imberti; Gualtiero Palareti; Franco Piovella 📂 Article 📅 2009 🏛 Springer Milan 🌐 English ⚖ 286 KB

PCV91 COST EFFECTIVENESS OF EXTENDED PRO

✍ B Van Hout; BV Pharmerit 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PMH14 THE COST-EFFECTIVENESS OF QUETIAPI

✍ G Meier 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PUK16 COST-EFFECTIVENESS OF VALGANCICLOV

✍ C. Vicente; A. Humar; C. Lemieux; R. Zilbershtein; P. Douglas; L. Formica; C. Pi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB